Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-04-22Clinical Trial Update: A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma [Phase 1, Phase 2]
BeOne Medicines is conducting a Phase 1b/2 trial of Sonrotoclax (BGB-11417) as a monotherapy and in combination with dexamethasone plus carf…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating outpatient administration of Teclistamab or Talquetamab in patients with multiple myeloma; currently recru…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Agriculture Health Study
The Agriculture Health Study (NCT00352924) remains active but not recruiting, continuing investigation into pesticide exposures and cancer r…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM) [Phase 3]
A Phase 3 trial protocol comparing belantamab mafodotin plus lenalidomide and dexamethasone (BRd) versus daratumumab plus lenalidomide and d…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Post-Op Pain Control for Prophylactic Intramedullary Nailing. [Phase 3]
Phase 3 clinical trial evaluating post-operative pain control after prophylactic intramedullary nailing. Sponsored by St. Louis University, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T) [Phase 2]
Phase 2 MATCH subprotocol T trial update reports testing vismodegib (GDC-0449) in cancers with SMO or PTCH1 mutations; the study is active b…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study [Phase 1, Phase 2]
This clinical trial update describes an ongoing Phase 1/2 study evaluating a quadruplet regimen of Iberdomide, daratumumab, bortezomib, and …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating SX-682 in combination with carfilzomib, daratumumab-hyaluronidase, and dexamethasone for relapsed or refra…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 1]
A Phase 1 clinical trial evaluating alnuctamab in combination with mezigdomide in relapsed/refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy [NA]
This clinical trial update outlines a study to define the role of palliative care for patients with hematologic malignancies undergoing adop…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial [NA]
A prospective randomized trial evaluating thiotepa in combination with melphalan as conditioning therapy for autologous stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma [Phase 2]
This Phase 2 clinical trial update evaluates [68Ga]Ga-PentixaFor-PET for initial staging and therapeutic evaluation in multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
A completed clinical trial update detailing a genome expression study in leukemia, multiple myeloma, and lymphomas (Hodgkin and Non-Hodgkin)…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: REal World MAIA UK OutcomEs
Update on a real-world UK outcomes study related to multiple myeloma is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma [Phase 2]
Phase 2 study evaluating iberdomide versus observation off therapy after idecabtagene vicleucel CAR-T therapy in adults with multiple myelom…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019B in Patients With Relapsed/Refractory Multiple Myeloma. [EARLY_Phase 1]
A Phase 1 clinical study to evaluate the safety and preliminary efficacy of QI-019B in patients with relapsed or refractory multiple myeloma…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: CAR T-cell Therapy in Patients With Renal Dysfunction [Phase 2]
A Phase 2 clinical trial evaluating CAR T-cell therapy in patients with renal dysfunction is currently recruiting for indications including …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
The document reports specimen collection activities for the Agricultural Health Study pesticide exposure cohort, a National Cancer Institute…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma [NA]
This entry reports on a completed clinical trial called The Myeloma Pack, which evaluates a multi-modality educational intervention to engag…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Regeneron is conducting a Phase 1/2 clinical trial evaluating linvoseltamab in adults with relapsed or refractory multiple myeloma, and the …
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease [Phase 2]
This update describes a Phase 2 trial evaluating a four-drug regimen (daratumumab, bortezomib, cyclophosphamide, and dexamethasone) for mult…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy [NA]
A clinical trial update describes a University of Nebraska study evaluating prebiotics to improve gut microbiome diversity after autologous …
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: BR101 in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating BR101 in patients with relapsed/refractory multiple myeloma. The study status is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects [Phase 1]
This listing describes a Phase 1 clinical trial evaluating Cemsidomide in combination with Elranatamab for relapsed/refractory multiple myel…
-
EMA approval · 2026-04-16EMA Authorised: Zolsketil pegylated liposomal (doxorubicin hydrochloride, liposomal) — Accord Healthcare S.L.U.
The EMA authorised Zolsketil pegylated liposomal doxorubicin for ovarian cancer, Kaposi sarcoma, and multiple myeloma. The Marketing Authori…